Research Infrastructure Core Abstract Our Research Infrastructure Core proposed in this renewal application is designed to meet the mission of creating technology and infrastructure for investigators/researchers conducting leading-edge translational research to improve health and eliminate health disparities. This Core is built upon established infrastructure at CDU through a combination of institutional funds (IDC), previous AXIS/RCMI/NIMHD funding support (2009- 2014 and 2014-2019), other Center grants, and Endowment funds. It will be supported through R01 projects, Pilot and Seed projects, Drug Discovery Unit, Clinical Research Resource Unit, Biomedical Informatics Unit, Research Method/Statistical Unit and ICTBD (Integrated Clinical and Tissue Biorepository/Biobank Data Base Core). The core is designed to combine the established research resource infrastructure in last two cycles of AXIS grant funding period that included Research Methods/Statistical Unit, Biomedical Information Unit, Clinical Research Resources and Facilities Unit and Laboratory Technology Unit. The guiding philosophy of this proposed combined Research Infrastructure Core is that although many projects can be advanced by using sophisticated genomic and cell biology techniques, their expense and difficulty of first use represent a significant barrier. The new combined Research Infrastructure Core with focus on Precision Medicine is specifically designed to overcome this barrier by providing training to CDU investigators that is not typically available in most next generation sequencing, genomics, bioinformatics, cell biology, or other specific core facilities. Moreover, this combined Research Infrastructure Core builds bridges among basic, clinical, behavior, and community- based researches by providing comprehensive support and services to investigators conducting translation research that includes Full-RO1 research projects proposed in this application and pilot and seed projects those have been or will be developed in the Investigators Development Core.

Public Health Relevance

The RCMI AXIS Program at CDU is designed to address health disparities through research in diseases that affect the community it serves and creating technologies and research infrastructure to serve the institutional scientific community and its academic and community partners. Our Research Infrastructure Core proposed in this renewal application is designed to meet the mission of creating technology and infrastructure for investigators/researchers conducting leading-edge translational research to improve health and eliminate health disparities. The new combined Research Infrastructure Core with focus on Precision Medicine is specifically designed to overcome this barrier by providing training to CDU investigators that is not typically available in most next generation sequencing, genomics, bioinformatics, cell biology, or other specific core facilities. Moreover, this combined Research Infrastructure Core builds bridges among basic, clinical, behavior, and community- based researches by providing comprehensive support and services to investigators conducting translation research that includes Full-RO1 research projects proposed in this application and pilot and seed projects those have been or will be developed in the Investigators Development Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD007598-13
Application #
10118044
Study Section
Special Emphasis Panel (ZMD1)
Project Start
2009-09-28
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
13
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Type
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Elsaid, Ahmed F; Shaheen, Magda; Ghoneum, Mamdooh (2018) Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial. Exp Ther Med 15:2313-2320
Sinha-Hikim, Amiya P; Mahata, Sushil K (2018) Editorial: Obesity, Smoking, and Fatty Liver Disease. Front Endocrinol (Lausanne) 9:1
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Schwartz, Steven; Bazargan-Hejazi, Shahrzad; Pan, Deyu et al. (2018) Association of Psychiatric Diagnostic Conditions with Hospital Care Outcomes of Patients with Orthopedic Injuries. Perm J 22:
Jenders, Robert A; Adlassnig, Klaus-Peter; Fehre, Karsten et al. (2018) Evolution of the Arden Syntax: Key Technical Issues from the Standards Development Organization Perspective. Artif Intell Med 92:10-14
Maxwell, Annette E; Castillo, Laura; Arce, Anthony A et al. (2018) Eating Veggies Is Fun! An Implementation Pilot Study in Partnership With a YMCA in South Los Angeles. Prev Chronic Dis 15:E132
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Hanuscin, Chris; Zahmatkesh, Golara; Shirazi, Anaheed et al. (2018) Socio-Demographic and Mental Health Profile of Admitted Cases of Self-Inflicted Harm in the US Population. Int J Environ Res Public Health 15:
Hasan, Mohammad Kamrul; Friedman, Theodore C; Sims, Carl et al. (2018) ?7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology 159:931-944
Berman, Barbara A; Jones, Loretta; Jones, Felica et al. (2017) How can we help African American substance users stop smoking? client and agency perspectives. J Ethn Subst Abuse :1-17

Showing the most recent 10 out of 190 publications